News | December 05, 2023
Cupid acquires land parcel near Mumbai
The acquisition will enable Cupid Limited to amplify its production capacity by 1.5 times the existing output
The acquisition will enable Cupid Limited to amplify its production capacity by 1.5 times the existing output
India had proposed for setting up the global standards for millets
The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene
The company also organised sensitization workshops for its employees aimed at increasing awareness of challenges faced by hearing-impaired individuals
A new GSK survey shows a large number of adults do not understand how shingles may be triggered
South Asia’s largest Trade Fair for pharma brought together over 50,000 visitors from across the globe, more than 1,500 exhibitors showcasing 10,000+ products and representation from over 80 countries
Accelerating FDA submission and confirming potential to become first approved biologic for this serious disease
Both the India and GCC entities will be operated by separate dedicated management teams
First-ever brain chemistry database will allow clinicians to quickly infer brain biomarker data to support the diagnostic process in conditions such as Alzheimer's Disease
Blenrep (belantamab mafodotin) plus BorDex showed statistically significant progression-free survival (PFS) benefit versus daratumumab plus BorDex
Subscribe To Our Newsletter & Stay Updated
